Astrana Health Narrows FY2026 Revenue Guidance to $3.9 Billion-$4 Billion
Bitget2026/11/05 22:35- Astrana Health forecasts fiscal 2026 revenue of $3.9 billion–$4 billion, implying 24.1% growth at the midpoint.
- Adjusted EBITDA guidance stands at $261 million–$274 million, representing 30.2% midpoint growth.
- Free cash flow is projected at $107.5 million–$130 million, implying 13.6% growth at the midpoint.
- Third-quarter revenue reached $1.02 billion; adjusted EBITDA totaled $77.2 million.
- Year-to-date consolidated medical cost trends are tracking below the full-year assumption of approximately 5.2%.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
British Pound hits session highs at 1.3420 amid broadbased US Dollar weakness
Cybertruck orders far exceed pre-production capacity, Tesla (TSLA.US) to refund deposits to a large number of customers
Elon Musk stated that Tesla will refund the Cybertruck deposits to a significant number of customers.
Barrick Gold (B.US) Q3 Results Mixed: Benefiting from Gold Price Dividend While Facing Cost Pressures
Barrick Mining (B.US) will release its financial results for the third quarter of 2026 before the U.S. stock market opens on November 9.
Crypto prices
More
